Penumbra (PEN) Peer Comparison
$320.08
$-1.03
(-0.32%)
As on 06-Nov-2026 11:43EST
Market cap
$12,682 Mln
Revenue (TTM)
$1,560 Mln
P/E Ratio
79.1
P/B Ratio
8.2
Div. Yield
0 %
Edit
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
12,682 | 14,302 | 11,234 | 10,876 | 5,149 |
Revenue ($ Mln) |
1,560 | 690 | 806 | 6,636 | 1,611 |
Net Profit ($ Mln) |
157.02 | -169.80 | -11.80 | 337.20 | 160.12 |
Net Margin (%) |
10.06 | -24.60 | -1.47 | 5.08 | 9.94 |
RoE (%) |
10.27 | -24.46 | -0.56 | 5.90 | 9.50 |
Price to Earnings |
79.11 | -- | -- | 32.10 | 32.30 |
Price-To-Book |
8.19 | 20.01 | 5.37 | 1.94 | 2.96 |
Income Statement ($ Mln)
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,560.33 | 690.33 | 805.61 | 6,635.60 | 1,611.15 |
|
Cost of Revenue
|
499.55 | 130.29 | 394.34 | 4,539.20 | 815.11 |
|
Gross Profit
|
942.44 | 393.22 | 347.62 | 2,139.40 | 736.94 |
|
Operating Expenses
|
871.54 | 623.34 | 392.34 | 1,593.70 | 578.68 |
|
Operating Profit (EBIT)
|
189.25 | -63.30 | 18.93 | 502.70 | 217.37 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
207.82 | -174.52 | 8.23 | 315.50 | 211.71 |
|
Provision for Tax
|
50.81 | -4.72 | 20.03 | -21.70 | 51.59 |
|
Profit after Tax (Net Income)
|
157.02 | -169.80 | -11.80 | 337.20 | 160.12 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Consolidated Profit
|
47.34 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,583.51 | 717.27 | 2,091.74 | 5,835.90 | 1,744.55 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
207.78 | 135.53 | 708.99 | 4,425.10 | 915.27 |
|
Current Liabilities
|
233.81 | 126.73 | 125.69 | 1,369.00 | 265.08 |
|
Total Liabilities
|
1,826.52 | 893.49 | 2,949.70 | 11,794.70 | 2,685.92 |
Assets ($ Mln)
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
648.47 | 399.88 | 1,684.42 | 9,037.40 | 1,726.09 |
|
Current Assets
|
1,376.63 | 579.65 | 1,241.98 | 2,592.60 | 1,198.82 |
|
Total Assets
|
1,826.52 | 893.49 | 2,949.70 | 11,794.70 | 2,685.92 |
|
Total Debt*
|
209.39 | 101.98 | 692.24 | 3,683.80 | 822.06 |
|
Net Current Assets
|
0.00 | 452.92 | 0.00 | 1,223.60 | 0.00 |
Cashflow ($ Mln)
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
238.66 | -46.34 | 117.42 | 623.80 | 297.37 |
|
Cash Flow from Investing Activities
|
-404.59 | -77.61 | -298.47 | -130.50 | -247.39 |
|
Cash from Financing Activities
|
26.53 | 11.89 | -15.21 | -409.40 | 16.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
11.76 | -22.53 | 1.79 | -5.43 | 5.52 |
|
ROE (%)
|
10.27 | -24.46 | -0.56 | 5.90 | 9.50 |
|
ROA (%)
|
5.91 | -15.48 | -0.33 | 2.57 | 4.58 |
|
EBIT Margin (%)
|
13.40 | -24.51 | 4.20 | 7.39 | 15.15 |
|
Net Margin (%)
|
10.06 | -24.60 | -1.47 | 5.08 | 9.94 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
16.98 | 46.94 | 13.80 | 0.92 | 9.18 |
|
EBIT Growth (%)
|
11.72 | -106.70 | 29.47 | 106.97 | 34.75 |
|
Net Profit Growth (%)
|
-4.27 | -93.80 | -779.17 | 510.22 | 35.20 |
|
EPS Growth (%)
|
-4.95 | -90.00 | -910.66 | 507.22 | 36.33 |
|
Book Value Growth (%)
|
15.61 | -12.58 | 0.35 | 4.89 | 13.20 |
Valuation Ratios
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
68.93 | -34.59 | 189.42 | -14.68 | 41.18 |
|
Price / Book Value
|
8.58 | 9.90 | 4.40 | 1.40 | 3.34 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
53.25 | -43.50 | 50.32 | 81.94 | 17.29 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 | 0.63 | 0.00 |
|
Short term debt to equity ratio
|
0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
|
Current Ratio
|
5.89 | 4.57 | 9.88 | 1.89 | 4.52 |
|
Quick Ratio
|
3.92 | 4.09 | 8.43 | 1.27 | 3.05 |
|
Interest Coverage
|
165.16 | -35.23 | 1.24 | 2.81 | 7.55 |
Operating Efficiency Ratios
| Penumbra (PEN) | Glaukos Corp (GKOS) | Repligen (RGEN) | Avantor (AVTR) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
12.51 | 21.73 | 18.77 | 16.92 | 16.12 |
|
Asset Turnover
|
0.59 | 0.63 | 0.22 | 0.51 | 0.46 |
|
Receivable days
|
46.54 | 60.95 | 72.41 | 58.79 | 52.18 |
|
Inventory Days
|
331.92 | 193.84 | 146.53 | 64.13 | 150.22 |
|
Payable days
|
26.16 | 60.19 | 29.05 | 58.13 | 30.30 |
|
Cash Conversion Cycle
|
352.30 | 194.60 | 189.88 | 64.79 | 172.09 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
